`Case 1:16-cv-00453-RGA Document 701-1 Filed 10/21/19 Page 1 of 12 PagelD #: 52387
`
`
`
`
`
`
`
`
`
`EXHIBIT A
`EXHIBIT A
`
`
`
`Case 1:16-cv-00453-RGA Document 701-1 Filed 10/21/19 Page 2 of 12 PageID #: 52388
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`26
`
`27
`
`28
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`UNITED STATES DISTRICT COURT
`
`SOUTHERN DISTRICT OF CALIFORNIA
`
`
`
`FINJAN, INC.,
`
`v.
`
`ESET, LLC et al.,
`
`
`
`Plaintiff,
`
`Defendants.
`
` Case No.: 17-CV-183-CAB-BGS
`
`ORDER ON MOTIONS FOR
`SUMMARY JUDGMENT AND
`MOTIONS TO EXCLUDE OR
`STRIKE
`[Doc. Nos. 466, 467,469, 470, 474, 476,
`
`
`
`478, 479, 481, 483, 484, 486, 488, 490,
`
`AND RELATED COUNTERCLAIMS
`
`492, 494, 497, 499, 501, 506, 509, 510,
`
`
`
`
`
`I.
`
`Introduction
`
`513, 515, 524, 526, 530, 531]
`
` At the close of fact and expert discovery and in accordance with the scheduling order
`
`in this case, the parties filed motions for summary judgment, Daubert motions challenging
`
`each other’s experts, and motions to exclude certain evidence. The Court provided no
`
`limitations regarding the number of dispositive motions that could be filed or total page
`
`limitations. The parties took extreme advantage of this and filed in total twenty-eight
`
`complex motions, putting before the Court an extraordinary number of issues purportedly
`
`without material facts in dispute and therefore proper for adjudication as a matter of law.
`
`Having reviewed the voluminous briefing, declarations and exhibits submitted by both
`
`1
`
`17-CV-183-CAB-BGS
`
`
`
`Case 1:16-cv-00453-RGA Document 701-1 Filed 10/21/19 Page 3 of 12 PageID #: 52389
`
`
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`parties, the Court concludes that for the majority of the substantive motions, facts were
`
`most definitely in dispute and summary judgment was not appropriate. Similarly, for the
`
`majority of the challenges to the admissibility of expert testimony, the Court concludes that
`
`the challenges go to the weight to be afforded the opinions. They are best challenged by
`
`cross-examination rather than deemed inadmissible and excluded as an exercise of the
`
`Court’s gatekeeper role.
`
`A number of the motions to exclude certain evidence centered on accusations of
`
`untimely disclosures and resulting prejudice to the moving party. These accusations flew
`
`in both directions, and the pages of briefing allocated to these arguments of attorney
`
`misconduct were exhausting. Generally, the Court concludes that there was no undue
`
`prejudice and that all of the evidence in question can be presented to a jury.
`
`Of the twenty-eight motions, the Court held a hearing on six motions on September
`
`26, 2019. [Doc. No. 679, transcript of 9/26/19 hrg.] Those six motions are addressed
`
`below. As to the remaining twenty-two motions, the Court issued tentative rulings [Doc.
`
`15
`
`No. 695] which remain unchanged.
`
`16
`
`17
`
`18
`
`II. ESET’s Motions
`
`A.
`
`Summary Judgment of Non-Infringement, License or Unenforceability
`
`The Court finds numerous material facts in dispute as to the following motions and
`
`19
`
`they are therefore DENIED.
`
`• Doc. No. 470 Motion for Non-Infringement of CMPS
`
`• Doc. No. 476 Motion for Non-Infringement of ‘621/’755 Patents
`
`• Doc. No. 481 Motion for Non-Infringement of ‘844 Patent
`
`• Doc. No. 484 Motion for Non-Infringement of ‘086 Patent
`
`• Doc. No. 488 Motion for Non-Infringement of ‘780 Patent
`
`• Doc. No. 486 Motion for License Defense
`
`• Doc. No. 531 Motion for Unenforceability of ‘086, ‘621 and ‘755 Patents
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`26
`
`27
`
`28
`
`
`
`2
`
`17-CV-183-CAB-BGS
`
`
`
`Case 1:16-cv-00453-RGA Document 701-1 Filed 10/21/19 Page 4 of 12 PageID #: 52390
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`26
`
`27
`
`28
`
`
`
`B. Motions to Exclude Experts and Strike Contentions
`
` The Court declines to exclude the experts contested in the motions listed below
`
`because their opinions are best challenged by cross-examination rather than exclusion. The
`
`motions are therefore DENIED. ESET’s request to strike Finjan’s Third Amended
`
`Infringement Contentions is also DENIED.
`
`• Doc. No. 474 Exclusion of Bims
`
`• Doc. No. 479 Exclusion of Mitzenmacher, Medvidovic, Goodrich and Cole
`
`• Doc. No. 469 Exclusion of Orso1
`
`• Doc. No. 492 Motion to Strike Third Amended Contentions
`
`III. FINJAN’s Motions
`
`A.
`
`Summary Judgment of Infringement or of ESET’s Defenses
`
`The Court finds numerous material facts in dispute as to the following motions and
`
`they are therefore DENIED.
`
`• Doc. No. 497 Motion for Infringement of ‘086 Patent
`
`• Doc. No. 499 Motion for Infringement of ‘621 Patent
`
`• Doc. No. 501 Motion for Infringement of ‘780 Patent
`
`• Doc. No. 506 Motion for No License Defense
`
`• Doc. No. 509 Motion for No Inequitable Conduct
`
`• Doc. No. 513 Motion for Validity over Certain Prior Art References
`
`B. Motions to Exclude Experts and Strike Evidence
`
` The Court declines to exclude the experts contested in the motions listed below
`
`because their opinions are best challenged by cross-examination rather than exclusion. The
`
`
`
`1 ESET moved to exclude the testimony of Dr. Alexxandro Orso regarding his opinions as to secondary
`considerations of non-obviousness. The Court RESERVES on this motion. ESET may voir dire this
`witness out of the presence of the jury to determine if his opinions are supported by the requisite nexus
`between the inventions and his conclusions regarding the secondary considerations of non-obviousness.
`
`3
`
`17-CV-183-CAB-BGS
`
`
`
`Case 1:16-cv-00453-RGA Document 701-1 Filed 10/21/19 Page 5 of 12 PageID #: 52391
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`26
`
`27
`
`28
`
`
`
`motions are therefore DENIED. Finjan’s motions to exclude certain prior art and non-
`
`infringing alternatives are also DENIED.
`
`• Doc. No. 510 Exclusion of Thompson
`
`• Doc. No. 515 Exclusion of Spafford
`
`• Doc No. 524 Exclusion of Britven
`
`• Doc. No. 530 Motion to Exclude Certain Prior Art
`
`• Doc. No. 526 Motion to Exclude Non-Infringing Alternatives.
`
`IV. The Remaining Motions
`
`A.
`
`Priority Dates [Doc. No. 483]
`
`As stated on the record at the hearing, this motion is DENIED as to ESET’s
`
`proposed priority dates for the ‘780, ‘086, ‘621 and ‘755 patents. There are material facts
`
`in dispute regarding whether the earlier patents to which Finjan claims priority disclose the
`
`inventions claimed in these patents.
`
`The Court, however, was prepared to adopt the IPR decision that the inventors of the
`
`‘844 patent were not in possession of the subject matter of the challenged claims of that
`
`patent any time prior to the December 22, 1997 filing date of the 08/995,648 application.
`
`[Doc. No. 483-20, at 21-25; Doc. No. 697, at 51.] The parties represented that there had
`
`been further developments in the Patent Office regarding that determination. The matter
`
`therefore remains under submission pending updates from the parties.
`
`B.
`
`ESET Motion re: Indefiniteness of “Downloadable” [Doc. No. 478]
`
`The genesis of this motion goes back to the claim construction of the term
`
`“Downloadable.” The Court references the claim construction order [Doc. No. 195], the
`
`portion of the claim construction hearing regarding this term [Doc. No. 610-3], and the
`
`portion of the hearing on this motion [Doc. No. 697 at 3:13-22:19] for context. In
`
`summary, the term “Downloadable” is defined by the inventor somewhat differently in the
`
`lineage of the patents at issue. In U.S. Patent No. 6,167,520, filed January 29, 1997, it is
`
`defined as, “a small executable or interpretable application program which is downloaded
`
`from a source computer.” In U.S. Patent No. 6,092,194, filed November 6, 1997 and
`
`4
`
`17-CV-183-CAB-BGS
`
`
`
`Case 1:16-cv-00453-RGA Document 701-1 Filed 10/21/19 Page 6 of 12 PageID #: 52392
`
`
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`incorporating the ‘520 patent, it is defined as “an executable application program which is
`
`downloaded from a source computer.” Both specifications use the sample examples of
`
`executable and interpretable application programs to identify what constitutes a
`
`“Downloadable.” Because both definitions are incorporated by reference throughout the
`
`patents, and the Court found they could be reconciled, the Court adopted the definition set
`
`for in U.S. Patent 6,167,520, that patent being incorporated into all the subsequent patents
`
`in the family tree.
`
`The definition of “Downloadable” in the ‘520 patent includes “small” as a
`
`description of the executable programs that are defined as a “Downloadable.” At the time
`
`of claim construction the Court noted that this term of size might lead to an indefiniteness
`
`issue if persons of skill in the art on January 29, 1997, the date the ‘520 patent was filed,
`
`did not understand what would constitute “small” with respect to “executable programs
`
`from a source computer that run on the destination computer.” That question, however,
`
`14
`
`was left for another day.2
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`26
`
`27
`
`28
`
`That day has come and ESET now contends that “Downloadable” is an indefinite
`
`term and as it is a claim limitation in all asserted claims of the five asserted patents, each
`
`is invalid under 35 U.S.C. § 112, which requires “that a patent’s claims, viewed in light of
`
`the specification and prosecution history, inform those skilled in the art about the scope of
`
`the invention with reasonable certainty.” Nautilus, Inc. v. Biosig Instruments, Inc., 572
`
`U.S. 898, 910 (2014). While there need not be precise numerical certainty, there must be
`
`no more than a “modicum of uncertainty.” Id.
`
`ESET has the burden of proving indefiniteness by clear and convincing evidence.
`
`Biosig Instruments, Inc. v. Nautilus, Inc., 783 F.3d 1374, 1377 (Fed. Cir. 2015). ESET
`
`presented evidence in its motion that Finjan’s experts had difficulty setting forth a
`
`
`
`2 Finjan’s objection that the defense of indefiniteness is untimely and should be struck is denied. This
`issue was identified at claim construction and Finjan was on notice that ESET would likely pursue it.
`
`
`5
`
`17-CV-183-CAB-BGS
`
`
`
`Case 1:16-cv-00453-RGA Document 701-1 Filed 10/21/19 Page 7 of 12 PageID #: 52393
`
`
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`26
`
`27
`
`28
`
`consistent understanding of how a person of skill in the art in 1997 would interpret a “small
`
`executable program.” Finjan countered that the kinds of programs identified as examples
`
`in the patent disclosure would provide adequate notice to a person of skill what was
`
`encompassed by the term “small.” Based on conflicting record before the Court, the Court
`
`cannot find at this time that ESET has demonstrated by clear and convincing evidence that
`
`the definition of “Downloadable” is indefinite. The motion for summary judgment is
`
`therefore DENIED without prejudice to ESET demonstrating this invalidity defense at
`
`trial.
`
`C. Exclusion of Dr. Ricardo Valerdi Testimony [Doc. No. 490]
`
`ESET moves to exclude the testimony of Dr. Ricardo Valerdi. Federal Rule of
`
`Evidence 702 creates “a gatekeeping role for the judge” to “ensure that an expert’s
`
`testimony both rests on a reliable foundation and is relevant to the task at hand.” Daubert
`
`v. Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579, 597 (1993). Dr. Valerdi offers an
`
`opinion employing a computer model to ascertain the cost he estimates that ESET incurred
`
`to develop and maintain the accused software incorporated into the accused products.
`
`Finjan however acknowledges that it has “verified ESET’s costs by analyzing (i) financial
`
`statements produced by ESET to estimate the maintenance and ongoing development costs
`
`ESET actually incurred related to the infringing systems; and (ii) the testimony of ESET’s
`
`head of finance, Ms. Jana Michalakova, regarding ESET’s actual development and costs
`
`related to the accused technologies for the relevant time period.” [Doc. No. 602 at 20.]
`
`Rather than rely on estimates derived from actual financial data, Finjan employed Dr.
`
`Valerdi to model the costs to develop and maintain the accused systems.
`
`This model is offered as evidence to support a cost savings analysis. Dr. Valerdi’s
`
`modeling however estimates the cost of developing the existing ESET software, not
`
`alternative non-infringing software. It therefore has no relevance to a cost savings analysis.
`
`“Reliance upon estimated cost savings from use of the infringing product is a well settled
`
`method of determining a reasonable royalty.” Hanson v. Alpine Valley Ski Area, Inc., 718
`
`F.2d 1075, 1080-81 (Fed. Cir. 1983). The comparison, however, should be to the costs of
`
`6
`
`17-CV-183-CAB-BGS
`
`
`
`Case 1:16-cv-00453-RGA Document 701-1 Filed 10/21/19 Page 8 of 12 PageID #: 52394
`
`
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`developing a non-infringing alternative. Prism Techs. LLC v. Sprint Spectrum L.P., 849
`
`F.3d 1360, 1376 (Fed. Cir. 2017) (costs saved by renting an infringing structure versus
`
`building a non-infringing structure). Dr. Valerdi’s modeling exercise is based not on
`
`creating a non-infringing alternative system, but on recreating the accused system.
`
`The Court finds no value in substituting the estimated actual costs of developing and
`
`maintaining ESET’s alleging infringing system with Dr. Valerdi’s model. Such modeling
`
`may be of assistance when actual costs cannot be determined, but that is not the situation
`
`here. Because the actual costs can be determined, Dr. Valerdi’s hypothetical construction
`
`of ESET’s costs is facially unreasonable. Such proposed testimony on the creation of
`
`unverifiable estimates from disputed inputs to come to a facially unreasonable hypothetical
`
`number as to the costs of developing and maintaining the accused technologies will be
`
`confusing and misleading to the jury, prejudicial to the defendant, and a waste of time. The
`
`motion to exclude the testimony of Dr. Valerdi is GRANTED pursuant to Federal Rule of
`
`14
`
`Evidence 403.
`
`15
`
`16
`
`17
`
`18
`
`D. Exclusion of Dr. Eric Cole Testimony [Doc. No. 494]
`
`ESET moves to exclude the testimony of Dr. Eric Cole. Dr. Cole provides opinions
`
`on the infringement of the ‘844 patent, the cost to ESET of implementing a non-infringing
`
`alternative to all the patents-at-issue, inputs for Dr. Valerdi’s cost estimation model, and
`
`19
`
`willfulness.
`
`The motion to exclude as to Dr. Cole’s opinion regarding infringement of the ‘844
`
`patent is DENIED. ESET challenges many of the assumptions and conclusions of Dr.
`
`Cole’s infringement opinion, but the Court concludes that is best left to cross-examination.
`
`Regarding Dr. Cole’s other opinions, however, the motion is GRANTED. The
`
`Court has excluded Dr. Valerdi’s testimony, therefore the Court strikes as irrelevant and
`
`confusing, under Rule 403, any testimony by Dr. Cole regarding the number of lines of
`
`code that make up the infringing functionality of the patents-at-issue. This testimony is
`
`also excluded in that Dr. Cole was not identified as an expert on the infringement of any
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`26
`
`27
`
`28
`
`7
`
`17-CV-183-CAB-BGS
`
`
`
`Case 1:16-cv-00453-RGA Document 701-1 Filed 10/21/19 Page 9 of 12 PageID #: 52395
`
`
`
`patents except the ‘844 patent. Consequently, his opinions of what source code executes
`
`the infringing functionality of the patents not within his purview are excluded.
`
`Dr. Cole’s opinion on the costs of ESET providing its services through a “non-
`
`infringing alternative,” (i.e., manually processing the files) is also excluded. Finjan
`
`acknowledged at the hearing on this motion that this proposed alternative is not viable.
`
`[Doc. No. 697, at 81:17-82:12.] Introducing the prohibitive cost and time of performing
`
`such processing manually, when it is recognized by all Finjan’s experts as a non-viable
`
`alternative, would only serve to mislead and confuse the jury and introduce a prejudicial
`
`damages figure into the discussion. It is excluded under Rule 403.3
`
`Similarly, Dr. Cole’s opinion regarding willfulness is excluded. Dr. Cole offers an
`
`opinion regarding what Finjan calls the standard of care in the industry. Based on Dr.
`
`Cole’s personal experience at McAfee, he would opine to the jury that a reasonable
`
`company would have reviewed Finjan’s “patented technology” upon learning of Finjan and
`
`its enforcement of its patent portfolio. Finjan concedes Dr. Cole does not opine on what
`
`ESET did – only what he believes similarly situated reasonable companies would have or
`
`should have done. [Doc. No. 589, at 16.]
`
`This opinion suggests that there is duty to investigate a competitor’s portfolio rather
`
`than a duty to determine if a known patent is infringed. Dr. Cole’s opinion is not whether
`
`ESET’s actions when it learned of specific Finjan patents was reasonable. He instead offers
`
`an opinion that a prudent company would be actively monitoring a competitor’s patent
`
`holdings and failure to do so is below a standard of care. This opinion is likely to mislead
`
`and confuse the jury in reaching a determination of whether ESET took due care to
`
`
`
`3 Finjan cited Prism Tech, 849 F.3d at 1375, for its holding that it was not error to admit cost savings
`evidence based on evidence of the cost Sprint would incur to avoid infringement by building a private
`network instead of leasing the services from third-party providers. Prism, however, discusses the costs
`and availability of this non-infringing alternative and evidence that Sprint could have attempted to build
`its own network. Id. at 1376-77. In this case, Finjan’s experts all agreed that the proposed manual
`processing system would not be a viable alternative, so introducing the purported exorbitant cost of
`implementing such a system is a distraction and misleading.
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`26
`
`27
`
`28
`
`8
`
`17-CV-183-CAB-BGS
`
`
`
`Case 1:16-cv-00453-RGA Document 701-1 Filed 10/21/19 Page 10 of 12 PageID #: 52396
`
`
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`determine if it was infringing after it learned of the patents at issue. The opinion is
`
`excluded under Rule 403 as well.
`
`E.
`
`Exclusion of Kevin Arst’s Testimony [Doc. No. 467]
`
`ESET moves to exclude the testimony of Kevin Arst, who is Finjan’s designated
`
`expert on a reasonable royalty. Despite the fact that Finjan has a history of licensing the
`
`patents at issue in this case, Mr. Arst apparently elected to ignore established royalty rates,
`
`or comparable licenses as benchmarks for his analysis.
`
`The reasonable royalty may be based upon an established royalty, if there is one, or
`
`if not upon a hypothetical royalty resulting from arm’s length negotiations between a
`
`willing licensor and a willing licensee. “Where an established royalty rate for the patented
`
`inventions is shown to exist, the rate will usually be adopted as the best measure of
`
`reasonable and entire compensation.” Hanson, 718 F.2d at 1078.
`
`Mr. Arst’s opinion is based instead on a cost savings analysis – the amount ESET
`
`14
`
`would reasonably pay in lieu of the cost it would incur to manually process files.4 [Doc.
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`No. 599, at 16 (Mr. Arst’s cost-savings opinions are based on Dr. Cole’s assessment that
`
`ESET would need to incur the full manual processing costs absent its infringement of the
`
`patents-in-suit.).] Although cost savings is a “well settled method of determining a
`
`reasonable royalty,” Hanson, 718 F.2d at 1080-81, the Court GRANTS the motion to
`
`exclude Mr. Arst’s cost savings opinion because the opinion is based on the unreliable
`
`assumption that manual processing is a viable alternative, when, as discussed supra with
`
`21
`
`respect to Dr. Cole’s opinion, it is not.
`
`22
`
`23
`
`24
`
`25
`
`26
`
`27
`
`28
`
`Finjan may revise Mr. Arst’s damages opinion, removing reliance on the opinions
`
`of Dr. Valerdi and Dr. Cole. He may not however introduce new materials. ESET will be
`
`
`
`4 Mr. Arst’s opinion also relies upon Dr. Valerdi’s analysis of the cost of developing and maintaining
`ESET’s existing system, as support for the cost “to build a new system.” Dr. Valerdi did not however
`estimate the cost of building a non-infringing alternative system and therefore provides no factual
`assumption to support Mr. Arst’s royalty analysis. The motion to strike Mr. Arst’s opinion relying on
`Dr. Valerdi’s modeling estimates is GRANTED.
`
`9
`
`17-CV-183-CAB-BGS
`
`
`
`Case 1:16-cv-00453-RGA Document 701-1 Filed 10/21/19 Page 11 of 12 PageID #: 52397
`
`
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`26
`
`27
`
`28
`
`given an opportunity to provide a responsive opinion and depose Mr. Arst on any revised
`
`opinion. [See Doc. No. 697, at 90:8-16.]
`
`F.
`
`Summary Judgment of No Willful Infringement and No Pre-Suit
`
`Damages [Doc. No. 466]
`
`ESET moves for summary judgment on Finjan’s allegation of willful infringement
`
`and to exclude any claim for damages prior to the filing of the complaint. Knowledge of
`
`the patent alleged to be willfully infringed is a prerequisite to enhanced damages. Halo
`
`Elecs., Inc. v. Pulse Elecs., Inc., 136 S. Ct. 1923, 1932-22 (2016). But knowledge of the
`
`patent itself is not enough. Finjan is required to show that ESET “acted despite a risk of
`
`infringement that was ‘either known or so obvious that it should have been known’” to
`
`ESET. WesternGeco LLC v. ION Geophysical Corp. 837 F.3d 1358, 1362 (Fed. Cir. 2016).
`
`Willful infringement is measured by the totality of the circumstances. Finjan claims
`
`that Eset should have known of Finjan’s patents, but Finjan presents no evidence that ESET
`
`was actually aware of any asserted Finjan patent prior to the receipt of a January 22, 2015
`
`letter from Finjan. [Doc. No. 466-4.] In that letter Finjan identifies two of the patents in
`
`suit, the ‘844 and ‘086 as relevant to ESET products or services, identifying specific
`
`products that correspond to those identified patents. Although no claim charts were
`
`provided in January 2015, at that time ESET was on notice of those two patents. No
`
`reference was made to, and therefore no notice was given as to the ‘780 patent. The ‘621
`
`patent and the ‘755 patent did not even issue until November 17, 2015, and December 22,
`
`2015, respectively, so it was an impossibility for the January 22, 2015 letter to constitute
`
`notice of infringement of those later issued patents.
`
`Following the January 22, 2015 letter, the parties entered into a Standstill Agreement
`
`to investigate whether there was infringement and to discuss potential licensing. [Doc. No.
`
`466-6.] That Agreement was continued until June 30, 2016. On July 1, 2016 this lawsuit
`
`was filed. During the term of the Standstill Agreement the parties agreed to disclose
`
`confidential information to assist in the discussion but that the disclosure of such
`
`information could not be used to establish a claim for damages or willful infringement.
`
`10
`
`17-CV-183-CAB-BGS
`
`
`
`Case 1:16-cv-00453-RGA Document 701-1 Filed 10/21/19 Page 12 of 12 PageID #: 52398
`
`
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`Finjan asserts that based on publicly available information, ESET knew throughout
`
`the pendency of Standstill Agreement that it was infringing the Finjan patents at issue and
`
`that it was negotiating in bad faith. The Court DENIES the motion for summary judgment
`
`of willful infringement but cautions Finjan that it must produce evidence at trial that ESET
`
`had knowledge of each of the asserted patents and committed subjective willful
`
`infringement as of the dates it became aware of those patents. The evidence of ESET’s
`
`knowledge cannot be based on disclosures made by Finjan during the Standstill Agreement,
`
`but rather must be independent of those discussions.
`
`With regard to notice, Finjan has presented no evidence it provided actual notice of
`
`infringement to ESET prior to January 22, 2015 for the ‘844 patent and ‘086 patent. Further
`
`Finjan has presented no evidence that it provided actual notice of infringement of the ‘780
`
`patent, the ‘621 patent and the ‘755 patent outside of disclosures subject to the Standstill
`
`Agreement provisions. The Court therefore finds that the damage period starts on January
`
`22, 2015 for the ‘844 patent and the ‘086 patent, and on the filing date of the complaint
`
`(July 1, 2016) for the ‘780 patent, the ‘621 patent, and the’755 patent.
`
`It is SO ORDERED.
`
`17
`
`Dated: October 16, 2019
`
`
`
`
`
`
`
`
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`
`
`24
`
`25
`
`26
`
`27
`
`28
`
`11
`
`17-CV-183-CAB-BGS
`
`